ROBERT HOLD: Open Payments
NPI 1003255613 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,454 in 41 payments from 5 companies in 2025. Trend: 2023 $727 · 2024 $497 · 2025 $3,454
Speaker / faculty: $2,500Food & beverage: $954
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 10 | $2,616 |
| Novo Nordisk Inc | 24 | $664 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $96 |
| Corcept Therapeutics | 2 | $44 |
| Currax Pharmaceuticals LLC | 2 | $33 |
Products named: ZEPBOUND, Wegovy, MOUNJARO, JARDIANCE, Korlym, Rybelsus, CONTRAVE, Ozempic.
Industry payments across NY — which companies pay providers there.
